Advance probably is the downward driving force as if it follows American hedge fund guidelines it will sell down and recoup it's cash outlay. It would not be interested in the share price. It would be interesting to be able to study the buy/sell identity to see if there was a relationship between the traders. This share price drop is highly intriguing as it is relentless in the face of the company being loaded with cash and in final human trials that, if I read the reports correctly, already are proven to work. Something's crook in Tallarook.
- Forums
- ASX - By Stock
- PAB
- melanoma trial
melanoma trial, page-4
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.6¢ | $903 | 131.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 2116616 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 888130 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 2116616 | 0.006 |
15 | 7449991 | 0.005 |
11 | 6764199 | 0.004 |
6 | 6065682 | 0.003 |
2 | 2770000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 888130 | 2 |
0.008 | 1661233 | 4 |
0.009 | 431000 | 1 |
0.010 | 396000 | 5 |
0.011 | 680000 | 2 |
Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |